Ascent Wealth Partners’s 9 Meters Biopharma NMTR Stock Holding History

Ascent Wealth Partners’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,261	Closed	-$22K	–	149
2022 Q2	$22K	Hold	4,261	–	–	﹤0.01%	134
2022 Q1	$51K	Hold	4,261	–	–	0.01%	146
2021 Q4	$83K	Hold	4,261	–	–	0.01%	144
2021 Q3	$111K	Hold	4,261	–	–	0.02%	147
2021 Q2	$94K	Hold	4,261	–	–	0.02%	146
2021 Q1	$100K	Buy	+4,261	New	+$131K	0.02%	119

Other funds holding NMTR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

ODFS

O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Ascent Wealth Partners's NMTR Position: Q3 2022 in Review

Ascent Wealth Partners sold out of 9 Meters Biopharma (NMTR) in Q3 2022, closing a stake of 4,261 shares — an estimated $22K sold.

Ascent Wealth Partners first reported a position in NMTR in Q1 2021 and held it in 6 quarters. The position peaked at $111K in Q3 2021. 74 funds tracked by Wall St. Rank hold NMTR as of Q3 2022.

Ascent Wealth Partners reported no remaining 9 Meters Biopharma position as of Q3 2022 after selling out during the quarter.
Ascent Wealth Partners sold 4,261 9 Meters Biopharma shares in Q3 2022, an estimated $22K.
Ascent Wealth Partners first reported a position in 9 Meters Biopharma in Q1 2021 and held it in 6 quarters.
Ascent Wealth Partners's 9 Meters Biopharma position peaked at $111K in Q3 2021.
74 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2022.

Based on Ascent Wealth Partners's 13F filing for Q3 2022, filed 14 Nov 2022.